Market Place
Sourcing Support
Melt Completes Dosing In MELT-300 Phase 3 For Cataract Surgery
10 Oct 2024 //
BUSINESSWIRE
Melt Pharmaceuticals Announces First Patient Dosed In Pivotal Phase 3 Program
06 Jun 2024 //
BUSINESSWIRE
Crossject announces highly successful closing of its €8 million rights offering
04 Jun 2024 //
GLOBENEWSWIRE
Crossject Publishes ZEPIZURE® Clinical Data In Neurology Journal
30 May 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of November 29, 2023
29 Nov 2023 //
FDA
NAYZILAM Results Published in `Epilepsy & Behavior`
31 Oct 2023 //
PR NEWSWIRE
Exela recalls 3 separate drugs over particulate concerns
27 Oct 2023 //
FIERCE PHARMA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Neuraxpharm completes its presence in Benelux by opening an affiliate
24 Jan 2023 //
PR NEWSWIRE
Melt Pharmaceuticals’ MELT-300 Achieves Primary Sedation Endpoint
21 Dec 2022 //
BUSINESSWIRE
Cipla`s Generic Midazolam Receives Approval in the U.S.
01 Nov 2022 //
FDA
Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector
30 Aug 2022 //
PRNEWSWIRE
CROSSJECT: Agreement with BARDA on ZENEO® Midazolam
18 Jun 2022 //
GLOBENEWSWIRE
Enforcement Report - Week of January 5, 2022
05 Jan 2022 //
FDA
Melt Pharmaceuticals Submits INDs for MELT?210 and MELT-400 to FDA
04 Jan 2022 //
BUSINESSWIRE
FDA Confirms Paragraph IV Patent Challenge of Midazolam Intravenous
03 Nov 2021 //
FDA
FDA warns Minnesota doc for running trials without INDs
19 Oct 2021 //
ENDPTS
Wavelength Expands Supplies of Key Drug Ingredients for Critically Ill COVID-19
20 Apr 2020 //
BIOSPACE
Wavelength Ups API Production for Essential Respiratory Meds
20 Apr 2020 //
CONTRACTPHARMA
CORRECTING & REPLACING Vizient Applauds FDA’s Temporary Policy Compounding
17 Apr 2020 //
BUSINESSWIRE
Coronavirus demand causes shortages of anesthetics, painkillers
14 Apr 2020 //
FIERCE PHARMA
Midazolam Injection, USP -Drug shortage
10 Apr 2020 //
FDA
FDA Reports Shortage of Sedation Drug Used for Putting COVID-19
03 Apr 2020 //
RAPS
FDA Reports Shortage of Sedation Drug Used for COVID-19 Patients on Ventilators
03 Apr 2020 //
RAPS
UCB Presents New Data Demonstrating Commitment to Epilepsy
05 Dec 2019 //
PR NEWSWIRE
UCB Announces availability of NAYZILAM® (midazolam) Nasal Spray CIV for seizure
25 Nov 2019 //
PR NEWSWIRE
Enforcement Report - Week of August 14, 2019
14 Aug 2019 //
FDA
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA
20 May 2019 //
PR NEWSWIRE
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA
20 May 2019 //
PR NEWSWIRE
Enforcement Report - Week of July 25, 2018
25 Jul 2018 //
FDA
US prison ‘fraudulently’ obtained sedative for lethal injection, claims Alvogen
12 Jul 2018 //
IN-PHARMATECHNOLOGIST
Imprimis`s to feature its patent-pending cyclosporine/chondroitin sulfate
10 Apr 2018 //
PR NEWSWIRE
Imprimis Jumps: Secures Patent for Non-Opioid Compound
27 Mar 2018 //
BIOSPACE
Enforcement Report - Week of January 10, 2018
10 Jan 2018 //
FDA
Virginia executes William Morva using controversial three-drug mixture
06 Jul 2017 //
THEGURDIAN
2 companies seek to block Arkansas from using their lethal injection drugs
13 Apr 2017 //
ORLANDOSENTINEL
Ohio is looking for a drug to reverse lethal injections
14 Jan 2017 //
STAT
Sobi & Horizon enter five-year distribution agreement for Ravicti & Ammonaps
07 Dec 2016 //
PR NEWSWIRE
Arkansas buys lethal injection drugs, aims to end execution hiatus
13 Aug 2015 //
REUTERS
Akorn Takes Steps to Prohibit its Drugs From Being Used for Executions
04 Mar 2015 //
PHARMALOT
Lethal Injection Case in Question as State Seeks New Drug
27 Jan 2015 //
BLOOMBERG BUSINESS
Research and Markets: China Sleep Disorder Treatment Drugs Markets Report 2015
21 Jan 2015 //
BUSINESS WIRE
